Patent ID: 7718802

Claim:
A compound of formula I or II: and pharmaceutically acceptable salts thereof; wherein J is a substituted or unsubstituted monocyclic or bicyclic ring structure, wherein in each instance the ring or rings have 5 or 6 ring atoms; L is a linker selected from the group consisting of —(CH 2 ) q —, —(CH 2 ) q —O—, —(CH 2 ) q —O—(C═O)—, —(CH 2 ) q —NH—, —(CH 2 ) q —NH—(C═O)—, —(CH 2 ) q —(C═O)—NH—, —(CH 2 ) q —(C═O)—O—, —NH—(C═O)—(CH 2 ) q —, —(C═O)—NH—(CH 2 ) q —, —NH—(CH 2 ) q —, —NH—(CH 2 ) q —O—, —(C═O)(CH 2 ) q —, —(CH 2 ) q —(C═O)—and —(C═O)—O—(CH 2 ) q —, q is from 0 to 6; W is a heteroatom unit with at least one cationic center, hydrogen bond donor or hydrogen bond acceptor selected from the group consisting of NH 2 , NH(C═NH)NH 2 , —NHCOCH 3 , —CONHCH 3 , —NH(C═NH)NHMe, —NH(C═NH)NHEt, —NH(C═NH)NHPr, —NH(C═NH)NHPr—I, —NH(C═NH)NH 2 , —NH(C═O)OCH 3 , —NH(C═O)CH 3 , —NH(C═O)NH 2 , —NH(C═O)NHCH 3 , Q represents a substituted or unsubstituted aromatic carbocyclic ring; R 6 is H, ═O, ═S or CH 3 ; R 7 is NH 2 , NH—R 8 , or R 8 is a C 1 to C 6 linear or branched chain or an amine capping group, and where there are two R 8 groups, each R 8 is independently a C 1 to C 6 linear or branched chain or an amine capping group, wherein the amine capping group is allyl, cyclopropane methyl, hexanoyl, heptanoyl, acetyl, propionoyl, butanoyl, phenylacetyl, cyclohexylacetyl, naphthylacetyl, cinnamoyl, phenyl, benzyl, benzoyl, 12-Ado, 7′-amino heptanoyl, 6-Ahx, Amc, 8-Aoc or polyethylene glycol with a formula molecular weight of between about 100 and about 10,000; y is from 0 to 6; z is from 0 to 6; and wherein the carbon atom marked with an asterisk can have any stereochemical configuration.